A team of researchers found bacteria linked to the gut in the brains of mouse models implanted with microelectrodes, breaching the blood-brain barrier. The discovery highlights the need for permanent strategies to prevent bacterial invasion from implanted devices, which can contribute to inflammation and reduced device performance.
A longitudinal study has found that tissue bridges in the spinal cord are associated with short- and long-term clinical improvements in patients with cervical spine injuries. The study's models, developed by a team of experts, incorporate tissue bridges for improved prognosis and can be transferred to other patient cohorts.
Researchers develop nanovector nanogels that selectively target glial cells involved in spinal cord injury inflammation, reducing damage and improving recovery. The treatment demonstrates potential for modulating glial cells in neurodegenerative diseases like Alzheimer's.
Developed by KAUST researchers, the system relies on users' facial expressions to accomplish tasks such as moving around outdoors and using elevators. The technology has shown promising results with three able-bodied users mastering it in under 15 minutes.
The study found that both aripiprazole and quetiapine were effective in improving symptoms of schizophrenia, particularly positive symptoms. However, aripiprazole demonstrated slightly better efficacy in general psychopathology and insight. No significant increase in extrapyramidal adverse effects was observed in either group.